Liesbeth De Jong

Title: Innovations by Liesbeth De Jong in Peripheral Artery Disease Treatment

Introduction

Liesbeth De Jong is an accomplished inventor based in Seville, Spain. She has made significant contributions to the field of medical technology, particularly in the treatment of lower extremity peripheral artery disease. Her innovative approach focuses on utilizing cell suspensions derived from bone marrow to enhance patient outcomes.

Latest Patents

Liesbeth holds a patent for a cell suspension intended for use in the treatment of lower extremity peripheral artery disease. The patent describes a cell suspension of autologous or allogeneic, preferably autologous, adult bone marrow-derived white blood cells. These cells are enriched for mononuclear cells, ensuring that more than 25% of the white blood cells present in the suspension are mononuclear cells. This innovative treatment aims to improve the efficacy of therapies for patients suffering from this condition.

Career Highlights

Throughout her career, Liesbeth has worked with notable organizations, including Fundación Pública Andaluza Progreso y Salud and Rexgenero Biosciences S.L. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Liesbeth has collaborated with esteemed colleagues such as Inmaculada Concepción Herrera Arroyo and Jonathan Robert Barclay Dupere. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical innovation.

Conclusion

Liesbeth De Jong's work in developing a cell suspension for treating lower extremity peripheral artery disease showcases her dedication to advancing medical technology. Her innovative contributions and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.